Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects

Diabetes Care

Volumn 30, Issue 5, 2007, Pages 1272-1274

  Mudra, Mitchell ^a   Ercan Fang, Nacide ^a,b   Zhong, Litao ^c   Furne, Julie ^a   Levitt, Michael ^a,b,d  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NatureGen Inc   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HYDROGEN; MULBERRY EXTRACT; PLACEBO; PLANT EXTRACT; SUCROSE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARBOHYDRATE ABSORPTION; CARBOHYDRATE INTOLERANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROGEN BREATH TEST; MULBERRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PLANT LEAF;

ADULT; AGED; BLOOD GLUCOSE; BREATH TESTS; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; HYDROGEN; HYPOGLYCEMIC AGENTS; MIDDLE AGED; MORUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; REFERENCE VALUES; SUCROSE;

EID: 34247648035     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2120     Document Type: Article

References (20)

1. Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S: Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol 50:161-164, 2004
2. Chen F, Nakashima N, Kimura I, Kimura M: Hypoglycemic activity and mechanisms of extracts from mulberry leaves (folium mori) and cortex mori radicis in streptozotocin-induced diabetic mice. Yakugaku Zasshi 115:476-482, 1995
3. Ye F, Shen ZF, Qiao FX, Zhao DY, Xie MZ: Experimental treatment of complications in alloxan diabetic rats with alpha-glucosidase inhibitor from the Chinese medicinal herb ramulus mori. Yao Xue Xue Bao 37:108-112, 2002
4. Murata K, Yatsunami K, Mizukami O, Toriumi Y, Hoshino G, Kamei T: Effects of propolis and mulberry leaf extract on type 2 diabetes. Focus Alternat Complement Ther 8:4524-525, 2003
5. Andallu B, Suryakantham V, Srikanthi BL, Reddy GK: Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes. Clin Chim Acta 314:47-53, 2001
6. 2 criteria. Gastroenterology 105:1404-1410, 1993
7. Suarez Fl, Zummaraga LM, Furne JK, Levitt MD: Nutritional supplements used in weight reduction programs increase intestinal gas in persons who malaborb lactose. J Am Diet Association 101:1147-1152, 2001
8. Zhong L, Furne JK, Levitt MD: An extract of black, green and mulberry teas causes malabsorption of carbohydrate but not triacylglycerol in health controls. J Clin Nutr 84:551-555, 2006
9. Oku T, Yamada M, Nakamura M, Sadamori N, Nakamura S: Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. Br J Nutr 95:933-938, 2006
10. U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
11. 1c-independent risk factor for diabetic complications. JAMA 295:1707-1708, 2006
12. Brownlee M: The pathphysiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
13. Monnier L, Mas E, Ginet C, Michael F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687, 2006
14. Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, Fucker K: Therapeutic potentials of acarbose as first line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 14:732-737, 1991
15. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M: The STOP-NIDDM trial: an international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance rationale, design, and preliminary screening data. Diabetes Care 21:1720-1725, 1998
16. Balfour JA, McTavish D: Acarbose: an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46:1025-1054, 1993
17. Taniguchi S, Asano N, Tomino F, Miwa I: Potentiation of glucose-induced insulin secretion by fagomine, a pseudo-sugar isolated from mulberry leaves. Horm Metab Res 30:679-683, 1998
18. Enkhamaa B, Shiwaku K, Katsube T, Kitajima K, Anuurad E, Yamasaki M, Yamane Y: Mulberry (Morus alba L.) leaves and their major flavonol queretin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J Nutr 135:729-734, 2005
19. Varadacharylul AB: Antioxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats. Clin Chim Acta 348:215-218, 2004
20. Srivastava S, Kapoor R, Thathola A, Srivastava RP: Mulberry (Morus alba) leaves as human food: a new dimension of sericulture. Int J Food Sci & Nutr 54:411- 416, 2003